BioNTech SE (BNTX)
108.36
+6.22
(+6.09%)
USD |
NASDAQ |
Nov 21, 16:00
108.77
+0.41
(+0.38%)
After-Hours: 20:00
BioNTech Price to Book Value: 1.217 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 1.147 |
| November 19, 2024 | 1.195 |
| November 18, 2024 | 1.144 |
| November 15, 2024 | 1.120 |
| November 14, 2024 | 1.163 |
| November 13, 2024 | 1.252 |
| November 12, 2024 | 1.194 |
| November 11, 2024 | 1.221 |
| November 08, 2024 | 1.242 |
| November 07, 2024 | 1.211 |
| November 06, 2024 | 1.198 |
| November 05, 2024 | 1.246 |
| November 04, 2024 | 1.224 |
| November 01, 2024 | 1.252 |
| October 31, 2024 | 1.270 |
| October 30, 2024 | 1.280 |
| October 29, 2024 | 1.280 |
| October 28, 2024 | 1.272 |
| October 25, 2024 | 1.241 |
| October 24, 2024 | 1.255 |
| October 23, 2024 | 1.246 |
| October 22, 2024 | 1.245 |
| October 21, 2024 | 1.253 |
| October 18, 2024 | 1.255 |
| October 17, 2024 | 1.285 |
| Date | Value |
|---|---|
| October 16, 2024 | 1.322 |
| October 15, 2024 | 1.320 |
| October 14, 2024 | 1.349 |
| October 11, 2024 | 1.353 |
| October 10, 2024 | 1.329 |
| October 09, 2024 | 1.319 |
| October 08, 2024 | 1.351 |
| October 07, 2024 | 1.365 |
| October 04, 2024 | 1.378 |
| October 03, 2024 | 1.345 |
| October 02, 2024 | 1.336 |
| October 01, 2024 | 1.347 |
| September 30, 2024 | 1.334 |
| September 27, 2024 | 1.375 |
| September 26, 2024 | 1.368 |
| September 25, 2024 | 1.347 |
| September 24, 2024 | 1.378 |
| September 23, 2024 | 1.315 |
| September 20, 2024 | 1.306 |
| September 19, 2024 | 1.308 |
| September 18, 2024 | 1.345 |
| September 17, 2024 | 1.450 |
| September 16, 2024 | 1.436 |
| September 13, 2024 | 1.435 |
| September 12, 2024 | 1.221 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8981
Minimum
Jun 28 2024
37.74
Maximum
Mar 18 2020
7.938
Average
2.274
Median
Price to Book Value Benchmarks
| Novavax Inc | -- |
| DBV Technologies SA | 0.8635 |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals PLC | 0.2294 |
| NuCana PLC | 0.5936 |
Price to Book Value Related Metrics
| PS Ratio | 7.918 |
| Price to Free Cash Flow | 25.37 |
| Price | 108.36 |
| Earnings Yield | -1.95% |
| Market Cap | 25.98B |